The NIMML tackles unsolved challenges in complex human diseases with unmet clinical needs. We combine advanced computational technologies with pre-clinical and clinical experimentation to catalyze translation of scientific discoveries into commercial applications that address unmet clinical or consumer needs.

NIMML History

The Nutritional Immunology and Molecular Medicine Laboratory (NIMML) is a research organization founded in 2002 under the guidance of Dr. Bassaganya-Riera and Dr. Hontecillas. NIMML is committed to a transdisciplinary, team-science approach with a personalized medicine focus at the interface of immunology, inflammation, and nutrition. The NIMML research programs incorporate drug development, nutritional immunology, computational immunology, and translational research in immune mediated, infectious, and chronic inflammatory diseases.

The NIMML research has pioneered pipelines applying high-throughput computational, experimental immunology techniques, and system biology approaches in translational immunology research and discovery. Through the Center for Modeling Immunity to Enteric Pathogens Program, we have applied high performance computing techniques to model and simulate human immunology systems and help immunologists conduct in silico experiments in order to develop a more mechanistic experimental design, validate hypotheses and save significant time and laboratory cost.

NIMML research has received support from the National Institute of Allergy and Infectious Disease at the National Institutes of Health, the National Center for Complementary and Alternative Medicine, Bristol Myers Squibb, Lipid Nutrition, Cognis Nutrition and Health GmbH, BASF, USDA, and commodity groups with a growing research funding portfolio exceeding $55 million.

About MIEP

The MIEP team develops and disseminates user-friendly mathematical and computational models for studying human immunity to infection of vaccination. MIEP combines mathematical modeling and immunology experimentation to characterize the mechanisms of underlying immune responses to enteric pathogens. Models, data, and tools become seamlessly integrated in MIEP’s modeling platform to advance the development of novel host-targeted therapeutics.

MIEP History

The Center for Modeling Immunity to Enteric Pathogens (MIEP) is a NIAID-funded program within the Nutritional Immunology and Molecular Medicine Laboratory. Under the guidance of Dr. Bassaganya-Riera (Principal Investigator), MIEP’s mission is to understand the mechanisms of action underlying immune responses to enteric pathogens.

Modeling Immunity for Biodefense-
MIEP is one of four NIAID-funded Centers in Modeling Immunity for Biodefense (MIB)

1. University of Rochester Center for Biodefense Immune Modeling
2. The Center for Computational Immunology
3. The Program for Research on Immune Modeling and Experimentation (PRIME)
4. The Center for Modeling Immunity to Enteric Pathogens (MIEP)

Our Mission

To comprehensively and systematically characterize mechanisms of action underlying infectious, metabolic and immune-mediated diseases; the NIMML will translate this new knowledge towards developing innovative therapeutics for human diseases that are safer and more effective.

Our Vision

To become a world-leading research laboratory in translational, personalized, predictive, participatory, and preventive medicine.

Our Values

Integrity, creativity, efficiency, teamwork, confidentiality, customer-service orientation, loyalty, commitment, trust, attention to detail, and impeccable work ethics.

Open positions

What NIMML Students Say

"The experiences I have had at NIMML are some of the most valuable of my undergraduate studies. The opportunities here have allowed me to utilize my knowledge gained from the classrooms to apply to the real world, aiding to push the boundaries of what we know in the field of immunology. I have grown as a student, a professional, and as a person at my time at NIMML."

- Eric Schiff

Please contact us if you would like to discuss the possibility of contributing financial support for our research. If you are ready to contribute a tax-deductible donation, please do the following:

  1. Go to http://www.givingto.vt.edu/MakingAGift/immediate-impact.html and follow the instructions.
  2. Under the specific area to support, please add: “VBI ref. #871982”
  3. Under Comments, please include: “For support of Nutritional Immunology and Molecular Medicine Laboratory Research”

Lab Presentation Schedule

Date Presenter Topic
12-02-16 Nuria Tubau-Juni
11-18-16 Andrew Leber
11-11-16 Meghna Verma
11-04-16 Michael Bagnoli Validation of site dependent ligand binding of LANCL2
10-28-16 Caroline Meyer LANCL2 Control of T cells in IBD
10-21-16 Nuria Tubau Juni Immunoregulatory role of LANCL2 in IBD
10-14-16 Michael Bagnoli Validation of site dependent ligand binding of LANCL2
10-07-16 Meghna Verma Social Media at NIMML
09-30-16 Bridget Marcinkowski Imaging of H. pylori in the gastric mucosa
09-23-16 Andrew Leber The role of epithelial cell NLRX1 in IBD